We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
-13.08%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$10.3B
AUM Growth
-$4.23B
Cap. Flow
-$2.33B
Cap. Flow %
-22.54%
Top 10 Hldgs %
22.12%
Holding
1,775
New
890
Increased
241
Reduced
317
Closed
326

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$139M
2
PYPL icon
PayPal
PYPL
+$91.4M
3
BDX icon
Becton Dickinson
BDX
+$83.3M
4
HON icon
Honeywell
HON
+$79M
5
PM icon
Philip Morris
PM
+$69.3M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$177M
2
EFX icon
Equifax
EFX
+$169M
3
MSFT icon
Microsoft
MSFT
+$163M
4
CI icon
Cigna
CI
+$159M
5
GPN icon
Global Payments
GPN
+$155M

Sector Composition

Rank Sector Weight
1 Healthcare 29.34%
2 Technology 14.72%
3 Financials 11.05%
4 Consumer Discretionary 10.74%
5 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWOU
1676
DELISTED
2U Inc
TWOU
-31,783
Closed -$71.7M
SLCA
1677
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-108,748
Closed -$2.05M
WRK
1678
DELISTED
WestRock Company
WRK
-76,550
Closed -$4.09M
TARO
1679
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-3,402
Closed -$334K
CAMP
1680
DELISTED
CalAmp Corp.
CAMP
-3,025
Closed -$1.67M
PXD
1681
DELISTED
Pioneer Natural Resource Co.
PXD
-2,600
Closed -$453K
KAMN
1682
DELISTED
Kaman Corp
KAMN
-17,243
Closed -$1.15M
CURO
1683
DELISTED
CURO Group Holdings Corp.
CURO
-20,923
Closed -$633K
IMGN
1684
DELISTED
Immunogen Inc
IMGN
-427,000
Closed -$4.04M
MRTX
1685
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-323,793
Closed -$15.3M
SFE
1686
DELISTED
Safeguard Scientifics, Inc.
SFE
-13,371
Closed -$125K
AVTA
1687
DELISTED
Avantax, Inc. Common Stock
AVTA
-26,987
Closed -$1.09M
ACER
1688
DELISTED
Acer Therapeutics Inc
ACER
-39,872
Closed -$1.23M
SURF
1689
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-19,700
Closed -$216K
QUOT
1690
DELISTED
Quotient Technology Inc
QUOT
-11,981
Closed -$186K
BKI
1691
DELISTED
Black Knight, Inc. Common Stock
BKI
-6,317
Closed -$328K
ACGN
1692
DELISTED
Aceragen Inc
ACGN
-637
Closed -$96K
UNVR
1693
DELISTED
Univar Solutions Inc.
UNVR
-109,825
Closed -$3.37M
MGI
1694
DELISTED
MoneyGram International, Inc. New
MGI
-156,607
Closed -$837K
SJR
1695
DELISTED
Shaw Communications Inc.
SJR
-171,295
Closed -$3.33M
EVOP
1696
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
-89,079
Closed -$2.13M
RUBY
1697
DELISTED
Rubius Therapeutics, Inc
RUBY
-58,543
Closed -$1.41M
ALBO
1698
DELISTED
Albireo Pharma Inc
ALBO
-34,271
Closed -$1.13M
LHCG
1699
DELISTED
LHC Group LLC
LHCG
-5,865
Closed -$604K
TTM
1700
DELISTED
Tata Motors Limited
TTM
-112,534
Closed -$1.73M

Similar funds

Marshall Wace North America's Q4 2018 Portfolio in Review

As of Q4 2018, Marshall Wace North America held 1,775 positions worth $10.3B, down 29% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Marshall Wace North America withdrew a net $2.33B in Q4 2018, closing 326 positions and reducing 317 holdings. Its most notable exit was Equifax, an estimated $169M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Marshall Wace North America opened a new position in PayPal worth $92.3M.

  • Marshall Wace North America's largest Q4 2018 buy was PayPal: 1,097,757 shares worth $92.3M.
  • Marshall Wace North America added most to Comcast in Q4 2018, an estimated $139M increase.
  • Marshall Wace North America's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $177M.
  • Marshall Wace North America fully exited Equifax in Q4 2018, selling an estimated $169M.
  • Marshall Wace North America's ten largest holdings make up 22% of its $10.3B portfolio in Q4 2018.
  • Marshall Wace North America opened 890 new positions and closed 326 in Q4 2018.
  • Marshall Wace North America's portfolio value fell 29% quarter-over-quarter to $10.3B.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.